FOURTH AMENDMENT TO LEASELease • May 4th, 2018 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
THIS FOURTH AMENDMENT TO LEASE dated as of this 1st day of January, 2018 is by and between BP BAY COLONY LLC, a Delaware limited liability company (“Landlord”), and AMAG PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
Manufacturing Agreement Between Antares Pharma, Inc. and AMAG Pharmaceuticals, Inc.Manufacturing Agreement • May 4th, 2018 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Manufacturing Agreement (“Agreement”) is made and entered into as of the 20th day of March, 2018 (the “Effective Date”) by and between Antares Pharma, Inc., a Delaware corporation, with offices located at 100 Princeton South, Suite 300, Ewing, NJ 08628 (“Antares”), and AMAG Pharmaceuticals, Inc., a Delaware corporation, with a corporate address at 1100 Winter Street, Waltham, MA 02451 (“AMAG”). Antares and AMAG are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
ASSIGNMENT AND FIRST AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • May 4th, 2018 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Assignment and First Amendment to Development and License Agreement (the “Amendment”) is entered into as of the 20th day of March, 2018 (the “Effective Date”) by and between Antares Pharma, Inc., a Delaware corporation, with offices located at 100 Princeton South, Suite 300, Ewing, NJ 08628 (“Antares”), AMAG Pharma USA, Inc. (f/k/a Lumara Health Inc.), a Delaware corporation (“AMAG USA”), and AMAG Pharmaceuticals, Inc., a Delaware corporation, with a corporate address at 1100 Winter Street, Waltham, MA 02451 (“AMAG”) to amend the terms of that certain Development and License Agreement between Antares and AMAG USA, dated September 30, 2014 (the “Agreement”). Antares, AMAG USA and AMAG are sometimes referred to in this Amendment individually as a “Party” and collectively as the “Parties”.
